- Home
- PCVX vs ALLY Comparison
PCVX vs ALLY Comparison
Compare PCVX & ALLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- ALLY
- Stock Information
- Founded
- PCVX 2013
- ALLY 1919
- Country
- PCVX United States
- ALLY United States
- Employees
- PCVX N/A
- ALLY N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- ALLY Major Banks
- Sector
- PCVX Health Care
- ALLY Finance
- Exchange
- PCVX Nasdaq
- ALLY Nasdaq
- Market Cap
- PCVX 11.5B
- ALLY 11.3B
- IPO Year
- PCVX 2020
- ALLY 2014
- Fundamental
- Price
- PCVX $79.74
- ALLY $37.50
- Analyst Decision
- PCVX Strong Buy
- ALLY Buy
- Analyst Count
- PCVX 8
- ALLY 20
- Target Price
- PCVX $127.71
- ALLY $43.12
- AVG Volume (30 Days)
- PCVX 881.2K
- ALLY 3.1M
- Earning Date
- PCVX 02-25-2025
- ALLY 04-17-2025
- Dividend Yield
- PCVX N/A
- ALLY 3.20%
- EPS Growth
- PCVX N/A
- ALLY N/A
- EPS
- PCVX N/A
- ALLY 1.80
- Revenue
- PCVX N/A
- ALLY $6,816,000,000.00
- Revenue This Year
- PCVX N/A
- ALLY N/A
- Revenue Next Year
- PCVX N/A
- ALLY $9.08
- P/E Ratio
- PCVX N/A
- ALLY $20.94
- Revenue Growth
- PCVX N/A
- ALLY N/A
- 52 Week Low
- PCVX $58.10
- ALLY $31.95
- 52 Week High
- PCVX $121.06
- ALLY $45.46
- Technical
- Relative Strength Index (RSI)
- PCVX 36.96
- ALLY 46.15
- Support Level
- PCVX $82.03
- ALLY $36.75
- Resistance Level
- PCVX $84.10
- ALLY $39.45
- Average True Range (ATR)
- PCVX 3.12
- ALLY 0.90
- MACD
- PCVX -0.70
- ALLY -0.07
- Stochastic Oscillator
- PCVX 1.88
- ALLY 27.59
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About ALLY Ally Financial Inc.
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.